These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32116860)

  • 21. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.
    Kampman K; Jarvis M
    J Addict Med; 2015; 9(5):358-67. PubMed ID: 26406300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder.
    Peters ZJ; Kincaid MW; Greenberg JG; Quah RF; Curry JC
    Subst Abus; 2021; 42(4):638-645. PubMed ID: 32870103
    [No Abstract]   [Full Text] [Related]  

  • 24. Practical outpatient pharmacotherapy for alcohol use disorder.
    Kim Y; Hack LM; Ahn ES; Kim J
    Drugs Context; 2018; 7():212308. PubMed ID: 29445407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of pharmacotherapy for hazardous alcohol use among men who have sex with men: Findings from a qualitative study.
    Hsiang E; Jennings D; Matheson T; Hern J; Euren J; Santos GM
    Addict Behav Rep; 2018 Dec; 8():122-127. PubMed ID: 30258972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans.
    Leighty AE; Ansara ED
    Ment Health Clin; 2019 Nov; 9(6):392-396. PubMed ID: 31857935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
    Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH
    J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review.
    Slavin-Stewart C; Minhas M; Turna J; Brasch J; Olagunju AT; Chaimowitz G; MacKillop J
    Alcohol Clin Exp Res; 2022 Jan; 46(1):13-24. PubMed ID: 34825363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.
    Bromley E; Tarn DM; McCreary M; Hurley B; Ober AJ; Watkins KE
    J Subst Abuse Treat; 2020 Jul; 114():108007. PubMed ID: 32527506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of a clinical pharmacy specialist into a substance use disorder intensive outpatient treatment program to improve prescribing rates of alcohol use disorder pharmacotherapy.
    Dimitropoulos E; Bertucci S; Wong K
    Subst Abus; 2018; 39(2):190-192. PubMed ID: 29558338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-line Medications for the Outpatient Treatment of Alcohol Use Disorder: A Systematic Review of Perceived Barriers.
    Gregory C; Chorny Y; McLeod SL; Mohindra R
    J Addict Med; 2022 Jul-Aug 01; 16(4):e210-e218. PubMed ID: 34561352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with temporal priority in comorbid bipolar I disorder and alcohol use disorders: Results from the national epidemiologic survey on alcohol and related conditions.
    Goldstein BI; Levitt AJ
    J Clin Psychiatry; 2006 Apr; 67(4):643-9. PubMed ID: 16669730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies.
    Florence L; Lassi DLS; Kortas GT; Lima DR; de Azevedo-Marques Périco C; Andrade AG; Torales J; Ventriglio A; De Berardis D; De Aquino JP; Castaldelli-Maia JM
    Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
    Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population.
    Huskamp HA; Reif S; Greenfield SF; Normand ST; Busch AB
    J Gen Intern Med; 2020 Nov; 35(11):3262-3270. PubMed ID: 32754780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gender-focused perspective on health service utilization in comorbid bipolar I disorder and alcohol use disorders: results from the national epidemiologic survey on alcohol and related conditions.
    Goldstein BI; Levitt AJ
    J Clin Psychiatry; 2006 Jun; 67(6):925-32. PubMed ID: 16848652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
    Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
    J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.
    Williams EC; Young JP; Achtmeyer CE; Hendershot CS
    J Subst Abuse Treat; 2016 Nov; 70():14-20. PubMed ID: 27692183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding US addiction physicians' low rate of naltrexone prescription.
    Mark TL; Kranzler HR; Song X
    Drug Alcohol Depend; 2003 Sep; 71(3):219-28. PubMed ID: 12957340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.